Attached files
| file | filename |
|---|---|
| 10-K - PALISADE BIO, INC. | v214767_10k.htm |
| EX-31.2 - PALISADE BIO, INC. | v214767_ex31-2.htm |
| EX-32.2 - PALISADE BIO, INC. | v214767_ex32-2.htm |
| EX-31.1 - PALISADE BIO, INC. | v214767_ex31-1.htm |
| EX-21.01 - PALISADE BIO, INC. | v214767_ex21-01.htm |
| EX-23.01 - PALISADE BIO, INC. | v214767_ex23-01.htm |
| EX-10.07 - PALISADE BIO, INC. | v214767_ex10-07.htm |
Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Neuralstem, Inc. (the “Company”) Annual Report on Form 10-K for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, I. Richard Garr, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1). The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2). The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 16, 2011
/s/ I. Richard Garr
I. Richard Garr
Chief Executive Officer